Dr. Trebley is Co-founder and CEO of Scioto Biosciences and Monon Bioventures.
Mr. Schulz is a serial entrepreneur with over 20 years of financial experience working with public accounting firms, Fortune 500 companies and small start-up companies.
Mark L. Heiman, Ph.D. has 20+ years at Eli Lilly & Co where he served as researcher and CSO of obesity drug discovery.
Kevin Meyer has over 10 years of experience in the life sciences industry, having invented, patented, and commercialized a diverse portfolio of technologies.
Jaswant S. Gidda, Ph. D. has extensive drug discovery and development experience in big pharma (Eli Lilly & Co) and as an entrepreneur in biotechnology industry.